Food Allergy
FDA approves epinephrine nasal spray for anaphylaxis
The FDA has approved neffy epinephrine nasal spray for emergency treatment of Type 1 allergic reactions, including anaphylaxis, in pediatric and adult individuals weighing at least 66 pounds.
Strategies improve preparation for oral food challenges
SAN ANTONIO — Preparation is key to successful oral food challenges, said Maria Crain, APRN, CPNP-PC, AE-C, pediatric nurse practitioner, University of Texas Southwestern Medical Center Food Allergy Center.
Clinical decision support tool increases discussions about early peanut introduction
A clinical decision support tool prompted pediatric providers to ask families about introducing peanuts into their infants’ diets during well child visits, according to a study published in The Journal of Allergy & Clinical Immunology.
Top news of July: Anaphylaxis guidelines, epinephrine, FDA applications, more
Healio has compiled July’s most-read news in asthma and allergy.
House Appropriations Committee amendment requires peanuts in WIC food packages
The House Appropriations Committee adopted an amendment that would require the inclusion of peanut-containing products into the Special Supplemental Nutrition Program for Women, Infants, and Children.
Top in allergy/asthma: Modified anaphylaxis criteria; oral immunotherapy for children
A recent study found that health care professionals were increasingly able to identify infants and young children with anaphylaxis by following modified criteria.
Caregivers respond well after administering epinephrine during child oral food challenge
Giving young children an epinephrine autoinjection can be a positive and confidence-boosting experience for families, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Omalizumab rollout for food allergy patients requires care
In February, the FDA approved omalizumab for the reduction of food allergic reactions. First approved in 2003 for allergic asthma, this anti-IgE monoclonal antibody developed by Genentech and Novartis inhibits the allergic reaction process.
Seasonal, food allergies linked to higher alopecia areata risk
The risk of developing alopecia areata increases when both seasonal and food allergies are present, according to a study published in The European Journal of Allergy and Clinical Immunology.
Top in allergy/asthma: Efficacy of dry powder nasal epinephrine; COVID-19 asthma outcomes
A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.